Correlation Between Tonix Pharmaceuticals and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Pulmatrix, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Pulmatrix.

Diversification Opportunities for Tonix Pharmaceuticals and Pulmatrix

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Tonix and Pulmatrix is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Pulmatrix go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Pulmatrix

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Pulmatrix. In addition to that, Tonix Pharmaceuticals is 1.43 times more volatile than Pulmatrix. It trades about -0.16 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.06 per unit of volatility. If you would invest  293.00  in Pulmatrix on August 26, 2024 and sell it today you would earn a total of  319.00  from holding Pulmatrix or generate 108.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  Pulmatrix

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tonix Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Pulmatrix 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Tonix Pharmaceuticals and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and Pulmatrix

The main advantage of trading using opposite Tonix Pharmaceuticals and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Tonix Pharmaceuticals Holding and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency